| Year |
Citation |
Score |
| 2020 |
Gallagher EJ, LeRoith D. Hyperinsulinaemia in cancer. Nature Reviews. Cancer. PMID 32908223 DOI: 10.1038/S41568-020-0295-5 |
0.347 |
|
| 2020 |
Gallagher EJ, Fei K, Feldman SM, Port E, Friedman NB, Boolbol SK, Killelea B, Pilewskie M, Choi L, King T, Nayak A, Franco R, Cruz D, Antoniou IM, LeRoith D, et al. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Research : Bcr. 22: 40. PMID 32393319 DOI: 10.1186/S13058-020-01281-Y |
0.336 |
|
| 2020 |
Leiter A, Carroll E, Brooks DC, Shimol JB, Eisenberg E, Galsky M, Gallagher E. 1672-P: Characterization of Immune Checkpoint Inhibitor–Mediated Hyperglycemia: Beyond Insulin-Dependent Diabetes Diabetes. 69. DOI: 10.2337/Db20-1672-P |
0.367 |
|
| 2019 |
Senapati P, Kato H, Lee M, Leung A, Thai C, Sanchez A, Gallagher EJ, LeRoith D, Seewaldt VL, Ann DK, Schones DE. Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer. Epigenetics & Chromatin. 12: 44. PMID 31315653 DOI: 10.1186/S13072-019-0290-9 |
0.507 |
|
| 2018 |
Obr AE, Kumar S, Chang YJ, Bulatowicz JJ, Barnes BJ, Birge RB, Lazzarino DA, Gallagher E, LeRoith D, Wood TL. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment. Breast Cancer Research : Bcr. 20: 138. PMID 30458886 DOI: 10.1186/S13058-018-1063-2 |
0.361 |
|
| 2018 |
Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity and breast cancer. Endocrinology. PMID 30215698 DOI: 10.1210/En.2018-00574 |
0.31 |
|
| 2017 |
Shlomai G, Zelenko Z, Antoniou IM, Stasinopoulos M, Tobin-Hess A, Vitek MP, LeRoith D, Gallagher EJ. OP449 inhibits breast cancer growth without adverse metabolic effects. Endocrine-Related Cancer. 24: 519-529. PMID 28830934 DOI: 10.1530/Erc-17-0077 |
0.31 |
|
| 2017 |
Gallagher EJ, Zelenko Z, Tobin-Hess A, Werner U, Tennagels N, LeRoith D. Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes. Diabetologia. PMID 28229179 DOI: 10.1007/S00125-017-4225-3 |
0.362 |
|
| 2016 |
Gallagher EJ, Zelenko Z, Tobin-Hess A, Werner U, Tennagels N, LeRoith D. Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes. Diabetologia. PMID 27241182 DOI: 10.1007/s00125-016-4000-x |
0.363 |
|
| 2016 |
Gallagher EJ, LeRoith D, Franco R, Antoniou IM, Nayak A, Livaudais-Toman J, Bickell N. Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways. Diabetes/Metabolism Research and Reviews. PMID 26896340 DOI: 10.1002/Dmrr.2795 |
0.332 |
|
| 2016 |
Gallagher E, Leroith D, Feldman SM, Port ER, Friedman N, Pilewskie ML, Estabrook A, Boolbol SK, Franco R, Fei K, Bickell NA. Are racial differences in obesity and insulin resistance related to aggressive breast cancer? Journal of Clinical Oncology. 34: 1568-1568. DOI: 10.1200/Jco.2016.34.15_Suppl.1568 |
0.417 |
|
| 2016 |
Gallagher EJ, Leroith D, Franco R, Antoniou IM, Nayak A, Livaudais-Toman J, Bickell NA. Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: Hypothesis and proposed pathways Diabetes/Metabolism Research and Reviews. DOI: 10.1002/dmrr.2795 |
0.358 |
|
| 2015 |
Lin JJ, Fei K, Franco R, Gallagher E, Leroith D, Bickell NA. Racial differences in weight perception among breast cancer patients. Journal of Clinical Oncology. 33: e12623-e12623. DOI: 10.1200/Jco.2015.33.15_Suppl.E12623 |
0.324 |
|
| 2013 |
Belardi V, Gallagher EJ, Novosyadlyy R, Leroith D. Insulin and IGFs in obesity-related breast cancer Journal of Mammary Gland Biology and Neoplasia. 18: 277-289. PMID 24154546 DOI: 10.1007/S10911-013-9303-7 |
0.31 |
|
| 2011 |
Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Annals of the New York Academy of Sciences. 1243: 54-68. PMID 22211893 DOI: 10.1111/J.1749-6632.2011.06285.X |
0.314 |
|
| 2010 |
Gallagher EJ, LeRoith D. Insulin, insulin resistance, obesity, and cancer. Current Diabetes Reports. 10: 93-100. PMID 20425567 DOI: 10.1007/S11892-010-0101-Y |
0.32 |
|
| Show low-probability matches. |